ANDA 74539, held by Pharmachemie. Tamoxifen Citrate.
As of Nov 15, 2026, ANDA 74539 (Tamoxifen Citrate), held by Pharmachemie, was first approved by FDA on Mar 31, 2003, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 31, 2003 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tamoxifen CitrateEQ 10MG BASE ยท tablet;oral | Tamoxifen Citrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
